Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.Francesca Gay,Stefania Oliva,Maria Teresa Petrucci,Concetta Conticello,Lucio Catalano,Paolo Corradini,Agostina Siniscalchi,Valeria Magarotto,Luděk Pour,Angelo Michele Carella,Alessandra Malfitano,Daniela Petrò,Andrea Evangelista,Stefano Spada,Norbert Pescosta,Paola Omedè,Philip Campbell,Anna Marina Liberati,Massimo Offidani,Roberto Ria,Stefano Pulini,Francesca Patriarca,Roman Hajek,Andrew Spencer,Mario Boccadoro,Antonio PalumboThe Lancet Oncology(2015)引用 283|浏览23暂无评分关键词multiple myeloma,lenalidomide maintenance,chemotherapy,autologous transplantationAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要